Intrathecal pemetrexed for newly diagnosed leptomeningeal metastases: a multicenter, open-label, phase I/II study. Pan Z, Ye X, Huang Y, Tai P, et al. J Neurooncol 2025;175:857-868.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pan Z, Ye X, Huang Y, Tai P, et al. Intrathecal pemetrexed for newly diagnosed leptomeningeal metastases: a multicenter, open-label, phase I/II study. J Neurooncol 2025;175:857-868.
PMID: 40699526